These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16823931)

  • 1. Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid.
    Balboa JA; Cuello M; Cabrera O; del Campo J; Lastre M; Gil D; Taboada C; Fariñas M; Hernández M; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-63-4. PubMed ID: 16823931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New method for obtaining conjugated vaccines.
    Cabrera O; Cuello M; Soto CR; Martínez ME; del Campo JM; Pérez Oa; Infante JF; Sierra G
    Vaccine; 2006 Apr; 24 Suppl 2():S2-76-8. PubMed ID: 16823936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
    Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
    Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide-tetanus toxoid conjugates.
    Cabrera O; Martínez ME; Cuello M; Soto CR; Valmaseda T; Cedré B; González GS
    Vaccine; 2006 Apr; 24 Suppl 2():S2-74-5. PubMed ID: 16823935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
    Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
    Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
    Verheul AF; Van Gaans JA; Wiertz EJ; Snippe H; Verhoef J; Poolman JT
    Infect Immun; 1993 Jan; 61(1):187-96. PubMed ID: 8418041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines.
    Tontini M; Berti F; Romano MR; Proietti D; Zambonelli C; Bottomley MJ; De Gregorio E; Del Giudice G; Rappuoli R; Costantino P; ; Brogioni G; Balocchi C; Biancucci M; Malito E
    Vaccine; 2013 Oct; 31(42):4827-33. PubMed ID: 23965218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.
    Polotsky VY; Robbins JB; Bryla D; Schneerson R
    Infect Immun; 1994 Jan; 62(1):210-4. PubMed ID: 8262629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immune responses to meningococcal C polysaccharide-protein conjugate in mice.
    Cuello M; Cabrera O; del Campo JM; Parajón E; Sotolongo F; Camaraza MA; Arnet A; Suárez M; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-72-3. PubMed ID: 16823934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
    Konadu E; Shiloach J; Bryla DA; Robbins JB; Szu SC
    Infect Immun; 1996 Jul; 64(7):2709-15. PubMed ID: 8698499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
    Richmond P; Borrow R; Findlow J; Martin S; Thornton C; Cartwright K; Miller E
    Infect Immun; 2001 Apr; 69(4):2378-82. PubMed ID: 11254596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
    Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
    Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.
    Mehta OH; Norheim G; Hoe JC; Rollier CS; Nagaputra JC; Makepeace K; Saleem M; Chan H; Ferguson DJ; Jones C; Sadarangani M; Hood DW; Feavers I; Derrick JP; Pollard AJ; Moxon ER
    PLoS One; 2014; 9(12):e115713. PubMed ID: 25545241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.